Get the Weekly Intelligence Brief — top committee picks every Sunday.

ACAD vs CRL

ACADIA Pharmaceuticals Inc. vs Charles River Laboratories — AI-powered side-by-side comparison
ACAD
ACADIA Pharmaceuticals Inc.
61
Buy
VS
CRL
Charles River Laboratories
61
Buy
MetricACADCRL
AI Score 61 61
Price $30.59 $297.55
P/E Ratio 13.18× -61.69×
ROE 31.9% -4.6%
Revenue Growth YoY
Gross Margin 91.1% 32.2%
Debt / Equity 0.06× 1.07×
Dividend Yield 0.0% 0.0%
RSI (14) 61.2 79.8
Beta 0.845 1.376
Expected Upside +1.4%

AI Committee View

Current Innellis committee reasoning for ACAD versus CRL.
The committee scores are tied.

ACAD and CRL both score 61/100.

ACAD Committee View
60% agreement
5 analysts

The committee is genuinely divided. Growth Analyst sees a compelling case — quarter-over-quarter growth rate is accelerating, not just positive. Risk Analyst remains cautious — bollinger bandwidth of 21.2% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • Price structure making higher highs and higher lows — Technical
  • Trend and market structure agree -- coherent bullish picture — Technical
Bear Case
  • MACD histogram negative -- bearish momentum — Technical
  • Weekly RSI at 75 -- overbought on the larger timeframe too — Technical
  • Bollinger bandwidth of 21.2% signals elevated volatility — Risk
CRL Committee View
80% agreement
5 analysts

The committee is genuinely divided. Growth Analyst sees a compelling case — 5 consecutive earnings beats -- consistent execution. Risk Analyst remains cautious — bollinger bandwidth of 35.8% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • 5 consecutive earnings beats -- consistent execution — Growth
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • Price structure making higher highs and higher lows — Technical
Bear Case
  • RSI at 80 is in overbought territory — Technical
  • Weekly RSI at 87 -- overbought on the larger timeframe too — Technical
  • Bollinger bandwidth of 35.8% signals elevated volatility — Risk
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
ACAD Full Analysis CRL Full Analysis